淋巴结比率与淋巴结检出数对p16阳性口咽鳞癌局部区域复发的预后评估
该回顾性队列研究纳入2009至2017年间在单一机构接受颈淋巴结清扫的82例p16阳性口咽鳞状细胞癌患者,评估淋巴结比率(LNR)与淋巴结检出数(LNY)对局部区域无病生存期(LRDFS)的预后价值。基于LNR的风险模型预后判别能力优于第八版AJCC淋巴结分期(Harrell's C,0.9065 vs 0.7668)。
要点
- LNR≥0.129与p16阳性口咽鳞癌患者更差的2年LRDFS相关
- 淋巴结检出数(LNY)与LRDFS无显著关联
- 基于LNR的风险模型预后判别能力优于第八版AJCC淋巴结分期
核心结论
- LNR在预测p16阳性口咽鳞状细胞癌的局部区域无病生存期方面具有良好的预后价值,但需进一步评估。
研究设计与样本
- 回顾性队列研究,纳入2009至2017年在单一机构接受颈淋巴结清扫的82例p16阳性口咽鳞状细胞癌患者,评估局部区域无病生存期(LRDFS)。
- LNR与LNY的截断值通过时间依赖的受试者工作特征(ROC)曲线估算,并与第八版AJCC淋巴结分期比较预后意义。
主要发现
- 基于LNR的风险模型预后判别能力优于第八版AJCC淋巴结分期(Harrell's C,0.9065 vs 0.7668)。
关键数值与推荐
- 基于LNR的风险模型Harrell's C为0.9065,第八版AJCC淋巴结分期为0.7668。
临床怎么用
- 对于p16阳性口咽鳞状细胞癌患者,可考虑计算LNR以辅助预测局部区域复发风险。
- LNY在本研究中未显示独立预后价值,不应单独用于风险分层。
局限性
- 本研究为单中心回顾性队列,样本量82例,结论需进一步外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognostic value of lymph node yield (LNY) and lymph node ratio (LNR), or the ratio of number of metastatic LNs to total number dissected, has not been well established in p16-associated oropharyngeal squamous cell carcinoma (OPSCC). METHODS: This retrospective cohort study evaluated locoregional disease-free survival (LRDFS) in 82 patients with p16+ OPSCC who underwent neck dissection at a single institution from 2009 to 2017. LNR and LNY cutoffs were estimated using time-dependent receiver operator characteristic (ROC) curves. Prognostic significance of these cutoffs was compared with Eighth Edition AJCC Nodal Staging. RESULTS: An increased LNR ≥ 0.129 was associated with worse 2-year LRDFS (66.9% vs 96.8%, P = .005). LNY was not significantly associated with LRDFS (P = .304). An LNR-based risk model was a better prognosticator than Eighth Edition AJCC Nodal Staging (Harrell's C, 0.9065 vs 0.7668). CONCLUSIONS: LNR has good prognostic utility in predicting LRDFS in p16+ OPSCC, but further evaluation of this measure is warranted.
引用
- Nurimba M, Hines W, Sinha U, et al. Evaluation of lymph node ratio and lymph node yield as prognosticators of locoregional recurrence in p16-associated oropharyngeal squamous cell carcinoma. Head Neck. 2020. PMID: 32542889. doi:10.1002/hed.26324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。